E. Bramm
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Vitamin D Research Studies
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Oncology 11
- Drug Transport and Resistance Mechanisms 4
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Lise Binderup (28 shared papers)E. Arrigoni‐Martelli (20 shared papers)Scilla Latini (4 shared papers)Piet Geusens (4 shared papers)J. Dequeker (3 shared papers)Michael Kragh (3 shared papers)Torsten Skov (1 shared paper)Sumeer Dhar (1 shared paper)
- Journals
- Inflammation Research (8 papers)Calcified Tissue International (3 papers)Cellular and Molecular Life Sciences (3 papers)Scandinavian Journal of Immunology (3 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- DenmarkBelgiumUnited Kingdom
In The Last Decade
E. Bramm
36 papers receiving 892 citations
Peers
Comparison fields: 5 of 94
- Geriatrics and Gerontology 46
- Pathology and Forensic Medicine 218
- Orthopedics and Sports Medicine 95
- Physiology 46
- Immunology 171
Countries citing papers authored by E. Bramm
This map shows the geographic impact of E. Bramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bramm more than expected).
Fields of papers citing papers by E. Bramm
This network shows the impact of papers produced by E. Bramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bramm. The network helps show where E. Bramm may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Bramm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 290 | |
| 2 | CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo. | 1999 | 97 |
| 3 | 1997 | 48 | |
| 4 | Non-anti-coagulant heparin inhibits metastasis but not primary tumor growth. | 2005 | 46 |
| 5 | 2004 | 39 | |
| 6 | 1996 | 35 | |
| 7 | 1975 | 33 | |
| 8 | 2003 | 29 | |
| 9 | 1976 | 27 | |
| 10 | 2003 | 24 | |
| 11 | 1990 | 24 | |
| 12 | 1978 | 23 | |
| 13 | 1991 | 23 | |
| 14 | 1994 | 23 | |
| 15 | 1992 | 19 | |
| 16 | 1979 | 18 | |
| 17 | 1980 | 17 | |
| 18 | 1977 | 16 | |
| 19 | 1980 | 15 | |
| 20 | 1980 | 15 |
About E. Bramm
E. Bramm is a scholar working on Molecular Biology, Oncology, Pharmacology, Rheumatology and Immunology, having authored 38 papers that have together received 958 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (5 papers), Bone health and osteoporosis research (4 papers), Vitamin D Research Studies (4 papers), Inflammatory mediators and NSAID effects (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Geriatrics and Gerontology (46 citations), Pathology and Forensic Medicine (218 citations), Orthopedics and Sports Medicine (95 citations), Physiology (46 citations) and Immunology (171 citations). E. Bramm has collaborated with scholars based in Denmark, Belgium and United Kingdom. Frequent co-authors include Lise Binderup, E. Arrigoni‐Martelli, Scilla Latini, Piet Geusens, J. Dequeker, Michael Kragh, Torsten Skov, Sumeer Dhar, E. Jönsson and Rolf Larsson. Their work appears in journals such as Inflammation Research, Calcified Tissue International, Cellular and Molecular Life Sciences, Scandinavian Journal of Immunology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.